Nature's Sunshine Products (NATR)
(Delayed Data from NSDQ)
$13.32 USD
+0.40 (3.10%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $13.26 -0.06 (-0.45%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Nature's Sunshine Products, Inc. [NATR]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for NATR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
Consumer/Health - Wellness Watch: June 2015 Quarter Preview
Provider: Imperial Capital
Analyst: PINHEIRO M
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
1Q15 Update - Continued Near-Term Headwinds Outweigh Global Growth Potential
Provider: Imperial Capital
Analyst: PINHEIRO M
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
We are Initiating Coverage with an In-Line Rating and $15 Price Target
Provider: Imperial Capital
Analyst: PINHEIRO M
Company: Nature's Sunshine Products, Inc.
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for NATR
Provider: VALUENGINE, INC
|